Bluenote is an advanced AI-driven life sciences company focused on accelerating regulatory submissions by 50-75%. Trusted by leading pharmaceutical, medical device, diagnostics companies, CROs, and CDMOs, Bluenote's platform automates critical workflows to help organizations bring life-saving therapies to patients sooner.

The mission is to enable life sciences companies to focus resources on science instead of busywork by providing a platform that automates the creation of scientific and regulatory documents. Their AI assistants, agents, and workflow builders reduce the time required for producing first drafts, refining data presentations, automating repetitive tasks, and unlocking institutional knowledge in datasets.

Bluenote emphasizes enterprise-grade scalability, proven accuracy, seamless integration with customer data sources, and ease of use with no steep learning curves. The platform supports a wide range of documentation needs across pre-clinical, clinical, CMC, regulatory, quality, and commercial stages of product development.

Bluenote adheres to leading security and compliance standards including SOC 2 Type II and HIPAA, offers features like SAML SSO and IP allowlisting, and respects customer data privacy with zero data retention policies.